WO 2009/106980 #333
  • 3-Methyl-N-(1-{2-oxo-2-[4-(trifluoromethoxy)phenyl]ethyl}-1H-indazole-3-carbonyl)-L-valylglycinamide
  • N-{(2S)-1-[(2-Amino-2-oxoethyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}-1-{2-oxo-2-[4-(trifluoromethoxy)phenyl]ethyl}-1H-indazole-3-carboxamide
 4950  C25H26F3N5O5  533.5
 Cannabinoid
 InChI=1S/C25H26F3N5O5/c1-24(2,3)21(23(37)30-12-19(29)35)31-22(36)20-16-6-4-5-7-17(16)33(32-20)13-18(34)14-8-10-15(11-9-14)38-25(26,27)28/h4-11,21H,12-13H2,1-3H3,(H2,29,35)(H,30,37)(H,31,36)/t21-/m1/s1
 SVPBFQYEWMFCLB-OAQYLSRUSA-N This stereoisomer Any stereoisomer
 NC(=O)CNC(=O)[C@H](C(C)(C)C)NC(=O)c1nn(c2c1cccc2)CC(=O)c1ccc(cc1)OC(F)(F)F